Filter
240
Text search:
second-generation
Featured
Recommendations
20
New Publications
59
Language
Document type
No document type
182
Studies & Reports
25
Guidelines
21
Manuals
5
Fact sheets
4
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Ethiopia
9
Nepal
9
Liberia
8
Nigeria
8
Western and Central Europe
8
Uganda
7
India
7
Ukraine
6
Botswana
6
Global
5
Sierra Leone
4
Ghana
3
Philippines
3
Syria
3
Malawi
3
Eastern Europe and Central Asia
3
Eastern Europe
3
Guinea
2
Pakistan
2
South Sudan
2
Germany
2
Lebanon
2
Zambia
2
Kenya
2
Rwanda
2
Yemen
2
East and Southern Africa
2
West and Central Africa
2
Africa
2
Albania
2
Russia
2
Burkina Faso
1
Senegal
1
Zimbabwe
1
Haiti
1
Somalia
1
Jordan
1
Turkey
1
Tanzania
1
Indonesia
1
Mozambique
1
Sudan
1
Benin
1
Central African Republic
1
Namibia
1
Peru
1
Libya
1
Lesotho
1
Myanmar / Burma
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Asia
1
Djibouti
1
Southern Africa
1
Romania
1
Moldova
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
23
Women & Child Health
7
Public Health
6
Key Resources
3
Pharmacy & Technologies
3
Toolboxes
Mental Health
51
HIV
41
TB
10
Refugee
7
AMR
6
COVID-19
6
Ebola
4
Rapid Response
4
NTDs
4
Pharmacy
3
NCDs
3
Disability
2
Cholera
2
Conflict
2
Global Health Education
2
Natural Hazards
1
Zika
1
Planetary Health
1
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Summary Report on the Comprehensive Study
This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of their authors and do not necessarily reflect the views of USAID or th
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
PLoS Medicine Vol. 6 no. 10 (2009) e1000165
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Accessed: 04.10.2019
This handbook provides an overview of the law applicable to asylum, border management and immigration in relation to European Union (EU) law and the European Convention on Human Rights (ECHR). It looks at the situation of those foreigners whom the EU usually refers to as third-country nationals. Thi
...
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
